Respiratory Disease Testing Market, By Test Type (Imaging Test, Spirometry, Peak Flow Test, Blood Gas Test, Lung Volume Test, Others), By End User (Hospitals, Physician Offices, Clinical Laboratories), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Jul 2023

Code : CMI4030

Pages :178

Formats :

Excel and PDF

Industry : Medical Devices

Market Challenges And Opportunities

Global Respiratory Disease Testing Market– Driver

Rising incidence of respiratory diseases such as asthma, chronic obstructive pulmonary diseases (COPD), and bronchitis

Rising incidence of respiratory diseases such as asthma, chronic obstructive pulmonary diseases (COPD), and bronchitis is expected to drive the market growth over the forecast period. For instance, according to the World Health Organization, report in May 2020, asthma is the most common chronic disease among children worldwide and around 339 million people were living with asthma in 2020. Similarly, according to the same source, over 80% of asthma-related deaths occur in low-and lower-middle income countries.

Growing geriatric population

Growing geriatric population can also drive the Respiratory Disease Testing market growth. For instance, according to an article published in World Health Orgnisation, in November 2022, reported 1 in 6 people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world’s population of people aged 60 years and older will double (2.1 billion). Non-cystic fibrosis bronchiectasis is the most common in elderly and frailer patients with estimated cases of 50% in patients over 65 years of age and 19.1% in patients over 75 years old.

Restraints & Challenges: